Common Cold journal

download Common Cold journal

of 5

Transcript of Common Cold journal

  • 7/27/2019 Common Cold journal

    1/5

    Paediatrica IndonesianaVOLUME 52 NUMBER 6November

    Original Article

    324Paediatr Indones, Vol. 52, No. 6, November 2012

    Influence of zinc on severity of common cold

    in children

    Cahalafa Shinta Caesar, Mohammad Juffrie, Sumadiono

    AbstractBackgroundSymptomatic treatment of common cold in childrendoes not reduce the duration and severity of disease. Since zinc has

    been used to enhance cellular and humoral immunity, it has the

    potential to reduce the severity of the common cold. However, the

    effects of zinc on the common cold have been inconclusive. The

    use of zinc to treat cold symptoms deserves further studies.

    Objective To determine the effect of zinc supplementation onthe severity of the common cold in children.

    Methods:HSHUIRUPHGDUDQGRPL]HGGRXEOHEOLQGFRQWUROOHGWULDOLQFKLOGUHQDJHG\HDUVZKRZHUHGLDJQRVHGZLWKDFRPPRQ

    cold at primary health care centers in Gedongtengen, Umbulharjo

    ,DQG.RWDJHGH,,

  • 7/27/2019 Common Cold journal

    2/5

    Cahalafa Shinta Caesar et al: Influence of zinc on common cold severity

    Paediatr Indones, Vol. 52, No. 6, November 2012 325

    as disrupting and inhibiting the release of pro-

    inflammatory mediators.

    ,Q.XUXJ|OHWDOVUDQGRPL]HGFRQWUROOHGWULDO

    on the effects of zinc on the common cold, zinc had a

    significant effect in reducing the duration and severity

    of colds. However, Godfrey et al. reported inconsistent

    effects of zinc on cold severity. Since the evidencefor the effects of zinc on the common cold have been

    inconclusive, a further study is needed.

    Methods

    :HSHUIRUPHGDUDQGRPL]HGGRXEOHEOLQGFRQWUROOHG

    WULDOLQ$XJXVWWR-DQXDU\RQVXEMHFWVZLWK

    common cold received either zinc supplementation or

    placebo therapy. A pharmacist from an outside primary

    health care center held the key, so subjects and

    researchers were blinded until the end of the study.

    Diagnosis of common cold were based on cough and

    runny nose with clear or mucopurulent secretions of

    OHVVWKDQGD\VZLWKRUZLWKRXWPLOGIHYHURI&

    good general condition and no thoracic abnormalities

    RQSK\VLFDOH[DPLQDWLRQ:HLQFOXGHGVXEMHFWVDJHG

    \HDUVZKROLYHGLQRIWKH

    ]LQFSODFHERZDVWDNHQ:HGHILQHGH[SRVXUHWRVPRNH

    as exposure to cigarette smoke, kitchen smoke, or

    mosquito repellent smoke during the study. The study

    profile is shown inFigure 1.

    7KHHVWLPDWHGUHTXLUHGVDPSOHVL]HZDV

    calculated by unpaired categorical analysis with

    DDQGE6XEMHFWVZHUHFROOHFWHGE\

    consecutive sampling. The treatment group received

    ]LQFSRZGHU[PJIRUVHYHQGD\VZKLOHFRQWURO

    group received placebo powder. Any subject with

    fever received paracetamol. Subjects were assessed

    DWSULPDU\KHDOWKFDUHFHQWHUVRQWKHrdDQGth

    days of treatment. Nurses assessed the cough, nasal

    symptoms, throat symptoms and systemic symptoms

    WRGHWHUPLQHVHYHULW\RIGLVHDVH:HJDYHVFRUHVIRU

    HDFKFRPPRQFROGV\PSWRPQRV\PSWRPVPLOG

    V\PSWRPVPRGHUDWHV\PSWRPVDQGVHYHUH

    symptoms. After total scores were obtained, subjects

    ZHUHFODVVLILHGLQWRRIGLVHDVHVHYHULWLHVPLOGLI

    WKHWRWDOVFRUHZDVPRGHUDWHLI!WRDQG

    VHYHUHLI!WR&RPPRQFROGVHYHULW\DQGVLGH

    effects of the therapy were recorded by parents or

    $QDO\]HGQ

    /RVWWRIROORZXSQ

    $QDO\]HGQ

    /RVWWRIROORZXSQ

    Allocated to placebo groupQ

    Allocated to interventionJURXSQ

    5DQGRPL]HGQ

    $VVHVVHGIRUHOLJLELOLW\Q

    Excluded

    Did not meet inclusion criteria

    Q

    Declined participation (n=6)

  • 7/27/2019 Common Cold journal

    3/5

    Cahalafa Shinta Caesar et al: Influence of zinc on common cold severity

    326Paediatr Indones, Vol. 52, No. 6, November 2012

    nurses on study forms. The outcome of the study was

    the severity of the common cold. The condition was

    considered to be improved if there was a reduction of

    one degree or more compared to the prior assessment

    of severity.

    The independent variable in this study was the

    therapy type; zinc or placebo. The dependent variablewas severity of the common cold. Confounding factors

    were age, nutritional states, and initial degree of

    severity.

    This study was approved by the Commission on

    Medical Research Ethics and Health, Gadjah Mada

    University Medical School. All subjects provided

    proxy consent, signed by their parents.

    'DWDZDVDQDO\]HGZLWK6366IRU:LQGRZV

    7KHHIIHFWLYHQHVVRI]LQFFRPSDUHGZLWKWKDW

    of placebo therapy was analyzed by Chi-square

    test. Statistical significance was considered to be

    3

    Results

    7KH VXEMHFWVZHUH GLYLGHG LQWR WZR JURXSV

    Subjects in both groups had similar characteristics,

    as shown in Table 1.

    The decrease in severity of cold symptoms is

    shown in Table 2. There was no significant difference

    between the two groups in the decrease of cold

    V\PSWRPVHYHULW\3

    Table 1. Baseline characteristics of subjects

    Characteristics Zinc Placebo

    n=57 n=57

    Age, n (%)

    3-4 years

    4-5 years

    29

    28

    (51)

    (49)

    31

    26

    (54)

    (46)

    Sex, n (%)

    Male

    Female

    26

    31

    (46)

    (54)

    25

    32

    (44)

    (56)

    Nutritional status, n (%)

    Good

    Undernourished

    Overweight

    48

    7

    2

    (84)

    (12)

    (4)

    50

    7

    0

    (88)

    (12)

    0

    Smoke exposure, n (%)

    Yes

    No

    36

    21

    (63)

    (37)

    41

    16

    (72)

    (28)

    History of common cold contact, n (%)

    Yes

    No

    17

    40

    (30)

    (70)

    18

    39

    (32)

    (68)

    Length of illness, n (%)

    1 day

    2 days

    27

    30

    (47)

    (53)

    32

    25

    (56)

    (44)

    History of allergy, n (%)

    Yes

    No

    15

    42

    (26)

    (74)

    17

    40

    (30)

    (70)

    Attends school, n (%)

    Yes

    No

    36

    21

    (63)

    (37)

    33

    24

    (58)

    (42)

    Adherence to therapy, n (%)

    YesNo 561 (98)(2) 561 (98)(2)

    Additional therapy (paracetamol) given, n (%)

    Yes

    No

    29

    28

    (51)

    (49)

    35

    22

    (61)

    (39)

    Initial severity, n (%)

    Mild

    Moderate

    Severe

    52

    5

    0

    (91)

    (9)

    0

    48

    9

    0

    (84)

    (16)

    0

  • 7/27/2019 Common Cold journal

    4/5

    Cahalafa Shinta Caesar et al: Influence of zinc on common cold severity

    Paediatr Indones, Vol. 52, No. 6, November 2012 327

    One subject in the placebo group was considered

    WREHIDLOHGEHFDXVHKHWRRNDQWLELRWLFV:HLQFOXGHG

    this subject into group with did not decrease of severity

    of common cold. Secondary outcomes in terms of

    side effects (vomiting) occurred in 2 children in the

    zinc group and in 2 children in the placebo group

    (drowsiness). According to parents and nurses

    UHSRUWVDOOVXEMHFWVUHFHLYHGWKHUDS\ZLWK

    compliance.

    Discussion

    Previous study showed that zinc administration

    reduced the severity and shortened the duration

    of common cold. The duration of common cold in

    subjects who were given zinc was less than 5 days.

    However, our results were in contrast to this previous

    study. The common cold is self limiting disease with

    V\PSWRPVJHQHUDOO\UHPDLQLQJXSWRGD\VDQGXSWR

    GD\VLQRIFDVHVIn patients with a previoushistory of bronchial asthma, the common cold can be

    a trigger for asthma attacks. Thus reduction in the

    severity of common cold in children over time was

    expected.

    The difference in our results may have been

    due to insufficient zinc dosage. Previous studies

    have used varying doses of zinc. According to Eby,

    only zinc ions were shown to have anti-rhinovirus

    activity by inhibiting the normal cleavages by which

    the viral polypeptides are processed, inhibiting

    ,&$0LQFUHDVLQJOHYHOVRILQWHUIHURQJDPPD

    ,)1J), inhibiting the release of histamine and

    leukotrienes from basophils and mast cells, protecting

    the plasma cell membrane, and being useful in

    allergy treatment.:HXVHGDORZHUGRVHRI]LQF

    WKDQSUHYLRXVVWXGLHVEHFDXVHWKHPJRQFHGDLO\

    zinc dosage proved to be useful in other diseases. In

    addition, higher doses have been associated with

    adverse events.22

    Another possible reason for a lack of difference

    in the effects of zinc and placebo may be due to

    the type of viruses causing colds in our subjects.

    Current evidence has shown zinc to have an anti-

    UKLQRYLUXVHIIHFWWRRIFDVHVRIFRPPRQ

    cold are caused by rhinovirus), but there has been

    no evidence that zinc inhibits other cold-causing

    YLUXVHV7KHUHDUHPRUHWKDQW\SHVRIYLUXVHV

    that cause the common cold.)XUWKHUPRUHZH

    gave zinc to patients with symptom duration of

    > 24 hours, whereas there is evidence that zinc

    provides benefits only if administered within the

    first 24 hours.22

    A limitation of our study was that we did not

    perform intensive supervision after the treatment

    administration to both groups. Compliance to zinc

    administration was based on reporting by parents and

    families, hence, it is possible that the zinc was not

    taken regularly due to its unpleasant taste.

    Co-intervention at home in the form of foodand drink also were not explored. If the placebo

    group received more co-intervention than the zinc

    group, the results may have been influenced.25,26 The

    duration of the common cold was not defined as well

    because the data was compiled only up to the seventh

    day of observation. In addition, we found that side

    effects were not significantly different between the two

    JURXSV+RZHYHUVLQFHRXUVXEMHFWVZHUH\RXQJ

    years), they may not have been able to communicate

    their experience.

    ,QFRQFOXVLRQZHIRXQGWKDWPJRIRUDO]LQF

    supplementation once daily started in the first 48

    hours of cold duration did not significantly reduce

    WKHVHYHULW\RILOOQHVVLQFKLOGUHQDJHG\HDUV

    compared to a placebo. A further study needed to

    determine if a higher dosage of zinc and a different

    treatment duration can decrease the severity of the

    common cold.

    Table 2. Subjects with decreased cold severity in the zinc and the placebo groups

    Variable Zinc group

    n = 57

    Placebo group

    n = 57

    P value*

    Decreased severity status, n (%)

    Did not decrease

    Decreased

    11 (19)

    46 (81)

    12 (21)

    45 (79)

    0.83

    *Chi-square test

  • 7/27/2019 Common Cold journal

    5/5

    Cahalafa Shinta Caesar et al: Influence of zinc on common cold severity

    328Paediatr Indones, Vol. 52, No. 6, November 2012

    Acknowledgments

    :HWKDQNWKH+HDGVDQG6WDIIRIWKHSULPDU\KHDOWKFDUHFHQWHUV

    RI8PEXOKDUMR, .RWDJHGH,, DQG*HGRQJWHQJHQIRU WKHLU

    support.

    The authors declare that they have no conflict of interest

    in this research.

    References

    :+2&RXJKDQGFROGUHPHGLHVIRUWKHWUHDWPHQWRIDFXWH

    UHVSLUDWRU\LQIHFWLRQV LQ \RXQJ FKLOGUHQ *HQHYD :RUOG

    +HDOWK2UJDQL]DWLRQS

    2. Rajnik M. Rhinoviruses.>FLWHG$XJXVW@

    Available from: http://www.emedicine.com

    (E\*$+DQGERRNIRUFXULQJWKHFRPPRQFROGWKH]LQF

    lozenge story. Publications Division George Eby Research

    $XVWLQ7H[DV86$S

    'HSDUWHPHQ.HVHKDWDQ5HSXEOLN ,QGRQHVLD3HGRPDQ

    pemberantasan penyakit infeksi saluran pernafasan akut

    pada balita. 8th ed.-DNDUWD: 'HSDUWHPHQ.HVHKDWDQ5HSXEOLN

    ,QGRQHVLDS

    'HSDUWHPHQ.HVHKDWDQ5HSXEOLN,QGRQHVLD'DHUDK,VWLPHZD

    XQSXEOLVKHG@

    +XOLV] '7=LQFDQGWKH FRPPRQ FROGZKDW SKDUPDFLVWV

    QHHGWRNQRZ-$P3KDUP$VVRF

    *ZDOWQH\-0+D\GHQ)*Understanding colds>FLWHG

    2FWREHU@$YDLODEOHIURP http://www.commoncold.

    org/trtmnt.htm 'DUGHQQH0=LQFDQGLPPXQHIXQFWLRQ(XU-&OLQ1XWU

    6

    .XUXJ|O=$NLOOL0%D\UDP1.RWXURJOX*7KHSURSK\ODFWLF

    and therapeutic effectiveness of zinc sulphate on common

    FROGLQFKLOGUHQ$FWD3DHGLDWULFD

    *RGIUH\-& &RQDQW 6%6PLWK'67XUFR -+ 0HUFHU1

    *RGIUH\1+=LQFJOXFRQDWHDQGWKHFRPPRQFROGD

    FRQWUROOHGFOLQLFDOVWXG\-,QW0HG5HV

    :+2 &KLOG JURZWK VWDQGDUWV:HLJKW IRUDJH $YDLODEOH

    from: http://www.who.int/childgrowth/standards/weight_for_

    age/en/index.html

    0DUVKDOO,=LQFIRUWKHFRPPRQFROGUHYLHZ7KH&RFKUDQH

    /LEUDU\>FLWHG$SULO@$YDLODEOHIURPhttp://

    www.thecochranelibrary.com

    3UDVDG$6%HFN):%DR%6QHOO')LW]JHUDOG-7'XUDWLRQ

    DQGVHYHULW\RIV\PSWRPVDQGOHYHOVRISODVPDLQWHUOHXNLQ

    receptor antagonist, soluble tumor necrosis factor receptor,

    and adhesion molecules in patients with common cold treated

    ZLWK]LQFDFHWDWH-,QIHFW'LV

    0RVVDG 6%0DFNQLQ 0/ 0HGHQGRUS 69 0DVRQ3

    =LQFJOXFRQDWHOR]HQJHVIRUWUHDWLQJWKHFRPPRQFROGDrandomized, double-blind, placebo-controlled study. Ann

    Intern Med. ;

    3UDVDG $6)LW]JHUDOG -7 %DR% %HFN): &KDQGUDVHNDU

    PH. Duration of symptoms and plasma cytokine levels in

    patients with the common cold treated with zinc acetate:

    a randomized, double-blind, placebo-controlled trial. Ann

    ,QWHUQ0HG

    (E\*$'DYLV'5+DOFRPE::5HGXFWLRQLQGXUDWLRQRI

    common colds by zinc gluconate lozenges in a double-blind

    VWXG\$QWLPLFURE$JHQWV&KHPRWKHU

    7XUQHU5%+X\GHQ*)7KHFRPPRQFROG,Q%HKUPDQ5(

    .OLHJPDQ50-HQVRQ+%HGV1HOVRQWH[WERRNRISHGLDWULFV

    3KLODGHOSKLD6DXQGHUV(OVHYLHUS

    7RODQ5:, Nguyen MN.Rhinovirus infection.>FLWHG

    )HEUXDU\@$YDLODEOHIURPhttp://www.emedicine.com

    )ULHGODQGHU6/%XVVH::7KHUROHRIUKLQRYLUXVLQDVWKPD

    H[DFHUEDWLRQV-$OOHUJ\&OLQ,PPXQRO

    2YHUEHFN6 5LQN / +DDVH+ 0RGXODWLQJ WKHLPPXQH

    response by oral zinc supplementation: a single approach

    IRUPXOWLSOHGLVHDVHV$UFK,PPXQRO7KHU([S

    (E\*$=LQFOR]HQJHVDVFXUHIRUWKHFRPPRQFROGDUHYLHZ

    DQGK\SRWKHVLV>FLWHG1 RYHPEHU@$YDLODEOHfrom: www.elsevier.com

    5R[DV0-XUHQND-&ROGVDQGLQIOXHQ]DDUHYLHZRIGLDJQRVLV

    and conventional, botanical, and nutritional considerations.

    $OWHUQ0HG5HY

    6LQJK0'DV55=LQFIRUWKHFRPPRQFROGUHYLHZ7KH

    &RFKUDQH/LEUDU\>FLWHG0DUFK@$YDLODEOH

    from: http://www.thecochranelibrary.com

    .HOO\-7%XVVH::+RVWLPPXQHUHVSRQVHVWRUKLQRYLUXV

    PHFKDQLVPVLQDVWKPD-$OOHUJ\&OLQ,PPXQRO

    -DFNVRQ-//HVKR(3HWHUVRQ&=LQFDQGWKHFRPPRQFROG

    DPHWDDQDO\VLVUHYLVLWHG-1XWU66

    26. Arrol B. Non-antibiotic treatment for upper-respiratory tract

    LQIHFWLRQVFRPPRQFROG5HVSLU0HG